Health care settlements

Purdue Pharma's bankruptcy test

Purdue Pharma headquarters building with tall grass in the foreground.
Purdue Pharma's bankruptcy filing won't end the lawsuits. Photo: John Moore/Getty Images

Purdue Pharma's first bankruptcy hearing starts today, commencing a process that will attempt to resolve 2,600 lawsuits that accuse the OxyContin maker of instigating an opioid crisis that has killed tens of thousands of Americans.

The big picture: Purdue is using bankruptcy as a tool to expedite legal remedies, but many state and local governments are ready to sue the Sackler family owners beyond bankruptcy court, arguing the family doesn't deserve bankruptcy protection.

Purdue Pharma reaches tentative opioids settlement

Purdue logo and sign outside of a headquarters building.
Photo: Drew Angerer/Getty Images

Purdue Pharma has tentatively reached the first "global" settlement in the nationwide opioids lawsuit, the New York Times and AP report. The plaintiffs later confirmed this to Axios.

The big picture: The deal would reportedly result in the maker of OxyContin entering bankruptcy and the Sackler family owners paying $3 billion over 7 years, among other terms. Some states still aren't on board with the proposal and may pursue Purdue and the Sacklers further, NYT reports. But the first major deal appears imminent ahead of the scheduled October trial.